Celiac.com Sponsor (A1):



Celiac.com Sponsor (A1-m):


0
Scott Adams

Glenmark To Begin Phase 2 Studies In Atopic Dermatitis, Celiac Disease - Healio

Rate this topic

Recommended Posts

Glenmark to begin phase 2 studies in atopic dermatitis, celiac disease

Healio

Glenmark Pharmaceuticals S.A. announced it has begun preparations to initiate phase 2 studies of GBR 830, a novel monoclonal antibody, in atopic dermatitis and celiac disease, according to a press release.

View the full article


Scott Adams

Celiac.com - Celiac Disease Board Moderator

Founder Celiac.com

Share this post


Link to post
Share on other sites

Join eNewsletter


Celiac.com Sponsor (A8):

Celiac.com Sponsor (A8):


Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

0


Join eNewsletter